ResultsIQ

ResultsIQ › Latest results › Fredun Pharmaceuticals Limited

Fredun Pharmaceuticals Limited call transcript summary

NSE: FREDUN · BSE: 539730

Call transcript of 6 Jun 2026, summarised by AI from the filing.

Fredun Pharmaceuticals will host its Q4 FY26 earnings conference call on Wednesday, 10th June, 2026 at 11:00 a.m.

Key takeaways

  1. Call date Fredun Pharmaceuticals will host its Q4 FY26 earnings conference call on Wednesday, 10th June, 2026 at 11:00 a.m.
  2. Dial-in Dial-in numbers are +91 22 6280 1239 and +91 22 7115 8140, with registration through a Chorus Call link.
  3. Speakers Mr. Fredun Medhora, Managing Director, is listed as the speaker from management.
  4. Organiser Kirin Advisors invited investors to the Q4 FY26 earnings call.
  5. Filing The intimation was filed with BSE under Regulation 30 of SEBI LODR Regulations, 2015.

Original filing on BSE

Fredun Pharmaceuticals Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.